Your browser doesn't support javascript.
loading
Hospitalization for hypoglycaemia in people with diabetes in Denmark, 1997-2017: Time trends in incidence and HbA1c and glucose-lowering drug use before and after hypoglycaemia.
Bengtsen, Mads Bisgaard; Knudsen, Jakob Schöllhammer; Bengtsen, Maria Bisgaard; Møller, Niels; Thomsen, Reimar Wernich.
Afiliação
  • Bengtsen MB; Department of Endocrinology and Internal Medicine Aarhus University Hospital Aarhus Denmark.
  • Knudsen JS; Department of Internal Medicine Regional Hospital of Horsens Horsens Denmark.
  • Bengtsen MB; Department of Clinical Epidemiology Institute of Clinical Medicine Aarhus University Hospital Aarhus Denmark.
  • Møller N; Department of Clinical Pharmacology Aarhus University Hospital Aarhus Denmark.
  • Thomsen RW; Department of Clinical Epidemiology Institute of Clinical Medicine Aarhus University Hospital Aarhus Denmark.
Endocrinol Diabetes Metab ; 4(3): e00227, 2021 Jul.
Article em En | MEDLINE | ID: mdl-34277957
ABSTRACT

OBJECTIVE:

To assess incidence trends of first hospitalization for hypoglycaemia in Denmark and to examine HbA1c levels and glucose-lowering drug use before and after hospitalization among individuals with type 1 or type 2 diabetes. RESEARCH DESIGN AND

METHODS:

We performed a population-based study linking diagnosis, prescription and laboratory data. Standardized incidence of first hospitalization for hypoglycaemia in Denmark was assessed for each calendar year 1997-2017. HbA1c and glucose-lowering drug use was compared with age- and sex-matched diabetes comparisons without hospitalization for hypoglycaemia.

RESULTS:

The annual age- and sex-standardized incidence rate of first hospitalization for hypoglycaemia per 100,000 person-years increased during 1997-2003 (from 17.7 to 30.3 per 100,000 person-years), remained stable until 2010 (30.4) and gradually declined until 2017 (22.0). During this period, we identified 3,479 people with type 1 diabetes and 15,329 people with type 2 diabetes experiencing first hospitalization for hypoglycaemia. Both diabetes groups experienced a mean HbA1c decrease of ~12%-15% in the months preceding first hospitalization, followed by a gradually increasing HbA1c afterwards. People with type 1 diabetes and hospitalization used similar insulin therapies as those without hospitalization. People with type 2 diabetes and hospitalization more often received insulin (55%) than comparisons (45%), and 45% discontinued insulin or stopped all glucose-lowering therapy after first hospitalization.

CONCLUSIONS:

Incidence of hospitalizations for hypoglycaemia has declined by one fourth the last decade in the Danish population. A HbA1c decrease precedes first hospitalization for hypoglycaemia in individuals with diabetes, and profound changes in glucose-lowering drug therapy for type 2 diabetes occur after hospitalization.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Endocrinol Diabetes Metab Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Hipoglicemia Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Endocrinol Diabetes Metab Ano de publicação: 2021 Tipo de documento: Article